Delivery Order SPE2DB22D1103-SPE2DB25FTFW9

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,018.05 firm fixed-price delivery order is for the supply of Pediarix 0.5 ML syringes, a pediatric combination vaccine. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. This delivery order is placed against Amerisourcebergen's $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,044.80, is for the delivery of Pediarix 0.5 ML syringes, a critical pediatric vaccine product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,086.24 firm fixed-price delivery order is for the supply of Pediarix 0.5 ML syringes, a pediatric combination vaccine. The contract has a completion date of June 28, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is valued at $1,960.94 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML syringes, a pediatric vaccine, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,520.46, is for the delivery of Pediarix 0.5 mL syringes, a vaccine product. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,565.80 firm fixed-price delivery order contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has an ultimate completion date of December 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $5,147.52, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML syringes, a pediatric combination vaccine. This is a firm fixed-price delivery order contract with a completion date of January 2, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,067.20 firm fixed price delivery order is for the supply of Pediarix 0.5 ML syringes, a vaccine product. The award is under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,215.50, is for the delivery of Pediarix 0.5 ML syringes, a pediatric combination vaccine. The contract is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,019.62, is for the delivery of Pediarix 0.5 ML syringes, a vaccine product. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 4, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a larger...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTFW9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,743.48 firm fixed-price delivery order is for the supply of Pediarix 0.5 ML Syringes, a vaccine product, with a completion date of February 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/1/25, 3:25 AM